Press release
Medical Grade Polydeoxyribonucleotide (PDRN) Market to Grow as Demand for Regenerative Medicine and Aesthetic Treatments Increases | Valuates Reports
Medical Grade Polydeoxyribonucleotide (PDRN) MarketPolydeoxyribonucleotide (PDRN) is a mixture of deoxyribonucleotides. It serves as an anti inflammatory and tissue regenerating agent. The mitogen activated protein kinase pathway modulates cell growth and collagen accumulation. It also regulates inflammation by suppressing the expression of proinflammatory cytokines. PDRN can rapidly induce tissue regeneration, promote cell regeneration, and accelerate wound healing. It is widely used in medical fields such as skin transplantation, burns, scars, and corneal regeneration.
The global Medical Grade Polydeoxyribonucleotide (PDRN) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-24A17236/Global_Medical_Grade_Polydeoxyribonucleotide_PDRN_Market_Research_Report_2024'
Medical Grade Polydeoxyribonucleotide (PDRN) Market Trends
The medical grade PDRN market size is expanding rapidly, driven by its growing application in regenerative medicine, wound healing, and aesthetic treatments. PDRN, derived from salmon DNA, is widely used in skin rejuvenation, anti-aging therapies, and tissue repair due to its ability to promote cell regeneration and collagen production. The increasing preference for minimally invasive procedures in dermatology and orthopedics is further fueling market growth.
In terms of market share, key players are focusing on innovation and clinical advancements to enhance the effectiveness of PDRN-based products. The demand for medical-grade PDRN injections, serums, and creams is rising across hospitals, dermatology clinics, and medical spas. Additionally, regulatory approvals and expanding R&D investments in biotechnology and regenerative medicine are contributing to the broader adoption of PDRN-based treatments.
A comprehensive market analysis indicates that the rising incidence of chronic wounds, diabetic ulcers, and orthopedic conditions is driving the need for biological healing solutions like PDRN. The integration of PDRN in combination therapies with PRP (platelet-rich plasma) and stem cell treatments is opening new growth avenues. With the increasing emphasis on non-surgical skin rejuvenation and regenerative therapies, the medical grade PDRN market is expected to witness strong demand, particularly in the Asia-Pacific and European regions.
by Type
• Freeze-dried Powder
• Solution
by Application
• Mesotherapy
• Bone Injection & Dermal Fillers
• Pharmaceutical
• Wound Healing Products and Others
By Company
HTL Biotechnology, ReaLi Tide Biological, PharmaResearch Co., Ltd., Humedix, Ruijiming Biological, HENGYU BIOPH, Mastelli, BR PHARM, BIOMEDIPHARM, BMI KOREA, BNF Solution, Bloomage Biotechnology Corporation
View full report
https://reports.valuates.com/market-reports/QYRE-Auto-24A17236/global-medical-grade-polydeoxyribonucleotide-pdrn
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,
Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Medical Grade Polydeoxyribonucleotide (PDRN) Market to Grow as Demand for Regenerative Medicine and Aesthetic Treatments Increases | Valuates Reports here
News-ID: 3921594 • Views: …
More Releases from Valuates Reports
Global Non Ferrous Metal Extrusion Press Market Research Report 2025
Non Ferrous Metal Extrusion Press Market
The global market for Non Ferrous Metal Extrusion Press was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Non Ferrous Metal Extrusion Press is estimated to increase from $ million in 2024 to reach $ million by 2031, at a…
Global Light Metal Extrusion Press Market Research Report 2025
Light Metal Extrusion Press Market Size
The global market for Light Metal Extrusion Press was valued at US$ 951 million in the year 2024 and is projected to reach a revised size of US$ 1269 million by 2031, growing at a CAGR of 4.3% during the forecast period.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-34J12183/Global_Light_Metal_Extrusion_Press_Market_Research_Report_2022
Light Metal Extrusion Press is a pressure forming process used in the manufacture of rods, pipes, wires as well as profiles,…
Global Extrusion Presses Market Research Report 2025
Extrusion Presses Market Size
The global market for Extrusion Presses was valued at US$ 951 million in the year 2024 and is projected to reach a revised size of US$ 1269 million by 2031, growing at a CAGR of 4.3% during the forecast period.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-15X6945/Global_Extrusion_Presses_Market_Insights_and_Forecast_to_2028
Extrusion Presses Market
Extrusion press is a pressure forming process used in the manufacture of rods, pipes, wires as well as profiles, above all of aluminum,…
Global Direct Extrusion Press Market Research Report 2025
Direct Extrusion Press Market Size
The global market for Direct Extrusion Press was valued at US$ 951 million in the year 2024 and is projected to reach a revised size of US$ 1269 million by 2031, growing at a CAGR of 4.3% during the forecast period.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-22Y12341/Global_Direct_Extrusion_Press_Market_Research_Report_2022
Direct Extrusion Press Market
Direct Extrusion Press is a pressure forming process used in the manufacture of rods, pipes, wires as well as profiles, above…
More Releases for PDRN
Salmon PDRN API Salmon PDRN API Market Poised for Accelerated Growth with a CAGR …
Market Summary -
The global market for Salmon PDRN API was estimated to be worth US$ 72.1 million in 2024 and is forecast to a readjusted size of US$ 540 million by 2031 with a CAGR of 32.5% during the forecast period 2025-2031.
According to QY Research, a new publication titled "Global Salmon PDRN API Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031" provides an in-depth, data-driven analysis of the…
Global Polydeoxyribonudeotide (PDRN) Sales Analysis Report: By Region, Players, …
Global Info Research's report offers key insights into the recent developments in the global Polydeoxyribonudeotide (PDRN) market that would help strategic decisions. It also provides a complete analysis of the market size, share, and potential growth prospects. Additionally, an overview of recent major trends, technological advancements, and innovations within the market are also included. Our report further provides readers with comprehensive insights and actionable analysis on the market to…
Polydeoxyribonucleotide (PDRN) Market Forecast Driven by Tissue Regeneration Dem …
Polydeoxyribonudeotide (PDRN) Market Size
The global market for Polydeoxyribonudeotide (PDRN) was valued at US$ 72.1 million in the year 2024 and is projected to reach a revised size of US$ 855 million by 2031, growing at a CAGR of 43.0% during the forecast period.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-16G12829/Global_Polydeoxyribonudeotide_PDRN_Market_Research_Report_2023
The polydeoxyribonucleotide (PDRN) market is witnessing a steady surge, propelled by growing interest in advanced regenerative treatments for wound healing, orthopedics, aesthetics, and sports-related injuries. PDRN-a…
Global PDRN Market Growth Accelerates with Innovation in Aesthetic Medicine and …
Polydeoxyribonudeotide (PDRN) Market Size
The global market for Polydeoxyribonudeotide (PDRN) was valued at US$ 72.1 million in the year 2024 and is projected to reach a revised size of US$ 855 million by 2031, growing at a CAGR of 43.0% during the forecast period.
Global key players of Polydeoxyribonudeotide (PDRN) include HTL Biotechnology and ReaLi Tide Biological. The top two players hold a share over 44%.
China is the largest market, has a…
Polydeoxyribonudeotide (PDRN) Market: Size, Share, Growth, Analysis, Key Players …
Polydeoxyribonudeotide (PDRN) Market Size
The global Polydeoxyribonudeotide (PDRN) market is projected to grow from US$ 52 million in 2024 to US$ 444.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 43.0% during the forecast period.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-16G12829/Global_Polydeoxyribonudeotide_PDRN_Market_Research_Report_2023
Market Trends for the Polydeoxyribonucleotide (PDRN) Market
1. Rising Demand for Regenerative Medicine
One of the primary factors driving the Polydeoxyribonucleotide (PDRN) market is the growing demand for regenerative medicine, especially in the treatment of…
Cosmetic Grade Polydeoxyribonudeotide (PDRN) Market Size, Revenue, Insights, Ove …
Cosmetic Grade Polydeoxyribonudeotide (PDRN) market is projected to reach US$ 284.9 million in 2029, increasing from US$ 26 million in 2022, with the CAGR of 43.3% during the period of 2023 to 2029.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-39D14950/Global_Cosmetic_Grade_Polydeoxyribonudeotide_PDRN_Market_Research_Report_2023
PDRN is deoxyribonucleic acid (DNA) product, mainly comes from semen and roe of fish, rapidly repair injured scars. It can promote the collagen synthesis on the cell surface, reverse aging signs. PDRN is the excellent…
